Vicia faba L.-derived peptides: Clinical Trials

1 trial of Vicia faba L.-derived peptides, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Enrolling by invitation 1

Follow Vicia faba L.-derived peptides: new trials by email Literature Review of Vicia faba L.-derived peptides trials Research Report on Vicia faba L.-derived peptides

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vicia Faba Peptides and Resistance Training in the Elderly
Vicia faba L.-derived peptides, Placebo, Supervised Resistance Training - Healthy Aging
Not applicableEnrolling by invitationUniversidade Cesumar (UNICESUMAR)772026-11-012026-10-07

Conditions studied

Sarcopenia (1)

Sponsors

Universidade Cesumar (UNICESUMAR) (1)

Countries

Brazil (1)

Top investigators

Vitor S Painelli, Dr (1)